New Delhi, March 10 -- Two of the world's largest pharmaceutical companies, a chemical manufacturer, and an auto giant have established internal artificial intelligence (AI) teams and opened centres to increase automation across their businesses, as the technology's rapid pace continues to upend business operations worldwide.

Over the last 18 months, Swiss life sciences major Novartis International AG and Texas-based chemical manufacturer Celanese Corporation started AI councils to identify segments that can be automated. Indiana-based Eli Lilly and Co. and South Korean carmaker Hyundai Motor Co. have opened AI-dedicated centres and increased research and development on internal usage of automation.

"The rise of GenAI and agentic AI is ...